Welcome to the fourth issue of Greenberg Traurig’s quarterly Behavioral Health Law Ledger, keeping behavioral health and integrated health providers current on behavioral health legal and regulatory developments. Each quarter we highlight recent legal developments, including but not limited to audit risks, significant litigation, enforcement actions, and changes to behavioral-health-related laws or regulations such as health privacy, confidentiality, and/or security issues, consent issues, data-sharing allowances, and other cutting-edge arrangements and issues facing behavioral and integrated health care providers.
In an effort to increase access to naloxone and potentially save lives, a bipartisan group of 30 lawmakers wrote to seven major naloxone manufacturers in April 2022, urging them to seek over the counter (OTC) status for naloxone, a medication that rapidly reverses an opioid overdose. See a copy of the letter.
The United States has seen a dramatic increase in opioid-related overdose deaths since the COVID-19 pandemic began. More than 107,000 deaths were reported in the United States between December 2020 and December 2021. Certain industry stakeholders raised questions for consideration in tandem with the OTC discussion, namely, how to address the cost of OTC naloxone to make it widely available when, as an OTC medication, it would no longer be covered by insurance.
Lawmakers noted the...
The National Board of Directors of the Union of Liberian Associations in the Americas (ULAA) hereby alerts the general public to a growing pattern of impersonation, misrepresentation, and the unau...